FDA Approved: XHANCE — Supplemental Application (OptiNose US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for XHANCE (fluticasone propionate) submitted by OptiNose US, Inc. The approval is categorized as a supplemental approva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• XHANCE (Fluticasone propionate)

Snippet

SUPPL AP for XHANCE (FLUTICASONE PROPIONATE)